Literature DB >> 8117940

Tumor necrosis factor-alpha: specific binding sites in rodent brain and pituitary gland.

D A Wolvers1, C Marquette, F Berkenbosch, F Haour.   

Abstract

Specific binding sites for TNF-alpha in mouse and rat brain, spleen and pituitary gland have been visualized and characterized, using quantitative autoradiography. Mouse recombinant 125I-TNF-alpha has been used as a radioligand. In the spleen, TNF-alpha binding sites were highly concentrated in the white pulpe of mouse and rat spleen. The IG50, as determined by displacement of radioligand by the unlabelled peptide, was 0.3 x 10(-9) M for both species. In the mouse brain, a weak specific binding was observed on the entire surface of the brain tissue. However, none of the nervous or vascular structures were specifically labelled above this signal. No specific binding was detectable in the rat brain tissue. In sharp contrast, in the anterior lobe of the pituitary gland of both mouse and rat, high concentrations of specific binding sites were detectable. Displacement curves in the mouse pituitary gland revealed the presence of two classes of binding sites with respective IC50 values of 10(-9) and 5 x 10(-11) M. A single class of TNF binding site was demonstrated in the rat with an IC50 of 10(-9) M. The presence of TNF binding sites in the anterior pituitary gland underlines the existence of regulatory pathways between the immune and neuroendocrine system.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8117940

Source DB:  PubMed          Journal:  Eur Cytokine Netw        ISSN: 1148-5493            Impact factor:   2.737


  9 in total

1.  Tumor necrosis factor alpha activates the phosphorylation of ERK, SAPK/JNK, and P38 kinase in primary cultures of neurons.

Authors:  G Barbin; M P Roisin; B Zalc
Journal:  Neurochem Res       Date:  2001-02       Impact factor: 3.996

Review 2.  Immune modulation of the hypothalamic-pituitary-adrenal (HPA) axis during viral infection.

Authors:  Marni N Silverman; Brad D Pearce; Christine A Biron; Andrew H Miller
Journal:  Viral Immunol       Date:  2005       Impact factor: 2.257

3.  Progesterone antagonizes the permissive action of estradiol on tumor necrosis factor-alpha-induced apoptosis of anterior pituitary cells.

Authors:  M Candolfi; G Jaita; V Zaldivar; S Zárate; L Ferrari; D Pisera; M G Castro; A Seilicovich
Journal:  Endocrinology       Date:  2004-11-04       Impact factor: 4.736

4.  Exacerbation of damage and altered NF-kappaB activation in mice lacking tumor necrosis factor receptors after traumatic brain injury.

Authors:  P G Sullivan; A J Bruce-Keller; A G Rabchevsky; S Christakos; D K Clair; M P Mattson; S W Scheff
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

5.  Vitamin E prevents ethanol-induced inflammatory, hormonal, and cytotoxic changes in reproductive tissues.

Authors:  Qianlong Zhu; Mary Ann Emanuele; Nancy LaPaglia; Elizabeth J Kovacs; Nicholas V Emanuele
Journal:  Endocrine       Date:  2007-10-16       Impact factor: 3.633

6.  A mechanism underlying the sexually dimorphic ACTH response to lipopolysaccharide in rats: sex steroid modulation of cytokine binding sites in the hypothalamus.

Authors:  Hajime Watanobe; Masashi Yoneda
Journal:  J Physiol       Date:  2003-01-10       Impact factor: 5.182

7.  Thyroid hormone antagonizes tumor necrosis factor-alpha signaling in pituitary cells through the induction of dual specificity phosphatase 1.

Authors:  Marina Lasa; Beatriz Gil-Araujo; Marta Palafox; Ana Aranda
Journal:  Mol Endocrinol       Date:  2009-12-23

8.  Tumor necrosis factor-alpha activates the human prolactin gene promoter via nuclear factor-kappaB signaling.

Authors:  Sönke Friedrichsen; Claire V Harper; Sabrina Semprini; Michael Wilding; Antony D Adamson; Dave G Spiller; Glyn Nelson; John J Mullins; Michael R H White; Julian R E Davis
Journal:  Endocrinology       Date:  2005-10-27       Impact factor: 4.736

9.  Effect of lipopolysaccharide on tumor necrosis factor and prolactin release from rat anterior pituitary cells.

Authors:  M S Theas; A De Laurentis; M Lasaga; D Pisera; B H Duvilanski; A Seilcovich
Journal:  Endocrine       Date:  1998-06       Impact factor: 3.925

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.